News | December 21, 2025
BPL Medical Technologies funds AI dept at Sri S Ramasamy Naidu Memorial College
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
The study found BIC/LEN to be statistically non-inferior to BIKTARVY, Gilead’s current standard-of-care therapy
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The move strengthens GBL’s clinical-stage presence in the United States
The combination also outperformed chemotherapy on another important secondary endpoint
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
Clinical trial enrollment has long been a bottleneck in drug development
Subscribe To Our Newsletter & Stay Updated
